Cargando…
Formalization, Annotation and Analysis of Diverse Drug and Probe Screening Assay Datasets Using the BioAssay Ontology (BAO)
Huge amounts of high-throughput screening (HTS) data for probe and drug development projects are being generated in the pharmaceutical industry and more recently in the public sector. The resulting experimental datasets are increasingly being disseminated via publically accessible repositories. Howe...
Autores principales: | Vempati, Uma D., Przydzial, Magdalena J., Chung, Caty, Abeyruwan, Saminda, Mir, Ahsan, Sakurai, Kunie, Visser, Ubbo, Lemmon, Vance P., Schürer, Stephan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498356/ https://www.ncbi.nlm.nih.gov/pubmed/23155465 http://dx.doi.org/10.1371/journal.pone.0049198 |
Ejemplares similares
-
BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results
por: Visser, Ubbo, et al.
Publicado: (2011) -
Evolving BioAssay Ontology (BAO): modularization, integration and applications
por: Abeyruwan, Saminda, et al.
Publicado: (2014) -
Facilitating transparency in spinal cord injury studies using data standards and ontologies
por: Lemmon, Vance P., et al.
Publicado: (2014) -
RegenBase: a knowledge base of spinal cord injury biology for translational research
por: Callahan, Alison, et al.
Publicado: (2016) -
An extension of the BioAssay Ontology to include pharmacokinetic/pharmacodynamic terminology for the enrichment of scientific workflows
por: Penn, Steve, et al.
Publicado: (2023)